Delivery Order SPE2DB24D2106-SPE2DB25FAVDF
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The single-award contract, valued up to $10,948.83, is a delivery order for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a firm fixed price pricing type and an ultimate completion date of April 5, 2024. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDV) with the DLA, contract SPE2DB24D2106,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $16,482.31 for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 26, 2025, with a completion date of February 27, 2025. The contract is a firm fixed-price delivery order and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a $31,320.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the supply of the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS, with an ultimate completion date of September 21, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $55,064.59 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products to fulfill the...
This is a firm fixed-price delivery order contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at up to $7,046.64, covers the delivery of Humira (CF) Pen 40 mg/0.4 mL to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,610.08 and covers the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialized pharmaceutical product, with a performance period ending on March 29, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This is a federal contract award made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $15,751.69 firm fixed-price delivery order is for the pharmaceutical product HUMIRA(CF) PEN 40 MG/0.4 MLS. The delivery order was issued against an indefinite delivery vehicle (IDV) contract, SPE2DB24D2106|SPE2DB24FAUAA, with a ceiling value of up to $4,999,999 through 2025. This IDV contract enables DLA to place orders for a broad range of...
This federal contract award, valued at $4,697.76, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC covers a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $35,289.60 firm fixed-price contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Department of Defense's Medical Supply Chain. The single-award indefinite delivery contract, valued at up to $3,078.84, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. It enables the DLA to place firm fixed-price delivery orders for a broad range of pharmaceutical items to support the recurring medical supply needs of...